Funded Tech Companies
ApoGen Biotechnologies
Wondering who provided funding to ApoGen Biotechnologies? M Capital, private investors and AbbVie Biotech Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
ApoGen Biotechnologies
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2815 Eastlake Ave. East 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Company Background Information
Overview
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/24/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Santini
Founder
Daniel Harki
Founder
Reuben Harris
Company Investors
- M Capital (Keno Gutierrez)
- AbbVie Biotech Ventures
- WuXi PharmaTech
- Alexandria Venture Investments
- Johnson & Johnson Development Corporation
- Arch Venture Partners
- WRF Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs